NCT01577732
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +24 more
- Locations
-
- GSK Investigational Site Haiphong, Vietnam
Clinical trial condition
Corynebacterium Infections
Explore clinical trials studying Corynebacterium Infections. Study availability and eligibility vary by location and protocol.
233 public trials
8 recruiting studies
Corynebacterium Infections trial results
NCT02853929
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +37 more
- Locations
-
- GSK Investigational Site Carlton, Victoria, Australia
- GSK Investigational Site Calgary, Alberta, Canada
- GSK Investigational Site Halifax, Nova Scotia, Canada
- GSK Investigational Site Montreal, Quebec, Canada
NCT00548171
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +8 more
- Locations
-
- GSK Investigational Site Westmead, New South Wales, Australia
NCT03950986
- Conditions
- Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +19 more
- Locations
-
- Atlanta VA Medical Center Decatur, Georgia, United States
NCT00352963
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +28 more
- Locations
-
- GSK Investigational Site Alcorcón, Spain
- GSK Investigational Site Almeira, Spain
- GSK Investigational Site Badalona, Spain
- GSK Investigational Site Barcelona, Spain
Completed
Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine.
NCT00835237
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +8 more
- Locations
-
- GSK Investigational Site Tucson, Arizona, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site DeLand, Florida, United States
- GSK Investigational Site West Palm Beach, Florida, United States
NCT00970307
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
- Locations
-
- GSK Investigational Site Bydgoszcz, Poland
- GSK Investigational Site Dębica, Poland
- GSK Investigational Site Krakow, Poland
- GSK Investigational Site Krakow, Poland
Completed
Post Market Surveillance for Infanrix™
NCT00908115
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
- Locations
-
- GSK Investigational Site Daegu, South Korea
NCT00463437
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +38 more
- Locations
-
- GSK Investigational Site Bad Saulgau, Baden-Wurttemberg, Germany
- GSK Investigational Site Bönnigheim, Baden-Wurttemberg, Germany
- GSK Investigational Site Bretten, Baden-Wurttemberg, Germany
- GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
NCT01353703
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
- Locations
-
- GSK Investigational Site Belgaun, India
- GSK Investigational Site Chennai, India
- GSK Investigational Site Pune, India
- GSK Investigational Site Pune, India